BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5089719)

  • 1. [Clinical experience in long-term treatment of gout with benzofuran iodine and bromine derivatives].
    Masbernard A; Guilbaud J; Droniou J
    Lyon Med; 1971 Apr; 225(8):683-91. PubMed ID: 5089719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gout treatment with a dibromine derivative of benzofuran].
    Delbarre F; Auscher C; Saporta L; de Grey A; Danchot J
    Rev Rhum Mal Osteoartic; 1973 Apr; 40(4):275-7. PubMed ID: 4716906
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hyperuricemic and gouty patients with derivatives of benzofuran].
    Delbarre F; Auscher C; Olivier JL; Rose A
    Sem Hop; 1967 Apr; 43(17):1127-33. PubMed ID: 4293531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 6. [Uricosuric and anti-gout action of certain benzofuran derivatives].
    Delbarre F; Auscher C; Amor B
    Presse Med (1893); 1965 Nov; 73(48):2725-6. PubMed ID: 5842108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N; Griebsch A; Fink JK
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thyrotoxicosis and benzidarone].
    Camus JP; Prier A; Kartun P; Mauguélis de Bourguesdon
    Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):148-50. PubMed ID: 4705339
    [No Abstract]   [Full Text] [Related]  

  • 9. [Benziodarone in the treatment of primary hyperuricemias].
    Bianco G; Marcolongo R; Carcassi A
    Minerva Med; 1968 Dec; 59(99):5470-81. PubMed ID: 5718835
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of L2214 in the treatment of gout or of rheumatologic syndromes associated with hyperuricemia].
    van Bogaert P
    J Belge Rhumatol Med Phys; 1969; 24(6):295-315. PubMed ID: 5403086
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R; Pagnan A; Fedele D; Novello M; Crepaldi G
    Policlinico Med; 1972; 79(3):151-64. PubMed ID: 5051107
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anuria due to bilateral ureteral uric acid lithiasis during a treatment with Amplivix].
    Navas P; Grasset D
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):466-9. PubMed ID: 4804419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hyperuricemia with benziodarone].
    Ravault PP; Vignon G; Lejeune E; Bouvier M; Queneau P
    Presse Therm Clim; 1970; 107(2):74-9. PubMed ID: 5468122
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of single oral doses of benzbromarone on serum and urinary uric acid.
    Jain AK; Ryan JR; McMahon FG; Noveck RJ
    Arthritis Rheum; 1974; 17(2):149-57. PubMed ID: 4814978
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results obtained with long-term benzbromarone therapy (author's transl)].
    Bresnik W; Müller MM
    Wien Klin Wochenschr; 1974 May; 86(10):283-7. PubMed ID: 4428763
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A
    Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
    [No Abstract]   [Full Text] [Related]  

  • 17. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone].
    Mugler A
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperuricemia and benziodarone].
    Haddad N; Zamouri A; Naccache S
    Tunis Med; 1973; 51(2):103-4. PubMed ID: 4784400
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of the hypo-uricemic action of benzbromarone in 40 cases of gouty and non-gouty hyperuricemia].
    Famaey JP; Vandenabeele G
    J Belge Rhumatol Med Phys; 1970; 25(1):5-9. PubMed ID: 5486285
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperuricemia and gout; treatment of an acute attack of gout].
    Gast LF; Cats A; van Romunde LK
    Ned Tijdschr Geneeskd; 1983 Dec; 127(49):2235-7. PubMed ID: 6656915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.